Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/28/20
End: 08/04/30
Due: 08/04/31
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer | NCT04420754 | AffyImmune Therapeutics, Inc. | user2@example.com | None | 2020-09-28 | 2030-08-04 | 2031-08-04 | - | - | 2025-07-14 |